Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 3.815.752.905.004.89

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 3.81 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20253.81
Mar20245.75
Mar20232.90
Mar20225.00
Mar20214.89

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 3.81
-33.74
Mar2024 5.75
98.28
Mar2023 2.9
-42.00
Mar2022 5
2.25
Mar2021 4.89 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹988.1 Cr -1.5% -6% 107.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

-1.5%

-6%

107.1%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses